| Recruiting | A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20- Systemic Lupus Erythematosus | Phase 1 | 2026-06-30 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Re Atherosclerosis | Phase 2 | 2026-04-30 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participa Diabetic Macular Edema | Phase 1 | 2026-04-22 |
| Recruiting | A Dose-Escalation Study of RO7875913 in Healthy Participants Healthy Volunteers | Phase 1 | 2026-03-11 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination Breast Cancer | Phase 1 | 2026-01-13 |
| Recruiting | A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healt Healthy Volunteers | Phase 1 | 2025-11-21 |
| Recruiting | A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy M Healthy Participants | Phase 1 | 2025-10-17 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in P Multiple Sclerosis | Phase 1 | 2025-10-15 |
| Recruiting | A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and G Breast Cancer | Phase 1 / Phase 2 | 2025-10-07 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderate Ulcerative Colitis | Phase 2 | 2025-09-29 |
| Recruiting | A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavol Hepatic Impairment | Phase 1 | 2025-08-21 |
| Completed | A Study to Evaluate the Relative Bioavailability of Two Tablet Formulations Compared to Capsule Formulation an Healthy Participants | Phase 1 | 2025-06-27 |
| Completed | A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Healthy Participants | Phase 1 | 2025-06-02 |
| Recruiting | A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulc Moderate to Severe Ulcerative Colitis | Phase 1 / Phase 2 | 2025-03-31 |
| Completed | A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy Participants Healthy Participants | Phase 1 | 2025-02-21 |
| Completed | A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired H Hepatic Impairment | Phase 1 | 2025-01-31 |
| Terminated | A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Acute Kidney Injury | Phase 2 | 2025-01-17 |
| Terminated | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combinati Solid Tumour | Phase 1 | 2024-12-16 |
| Recruiting | A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease Non-cystic Fibrosis Bronchiectasis, Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2024-11-18 |
| Completed | A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy Participants Healthy Participants | Phase 1 | 2024-11-15 |
| Recruiting | A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Solid Tumor | Phase 1 | 2024-11-14 |
| Completed | A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Gly Healthy Participants | Phase 1 | 2024-11-06 |
| Withdrawn | A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult | Phase 1 | 2024-09-30 |
| Active Not Recruiting | A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inh Chronic Lymphocytic Leukemia | Phase 2 | 2024-08-09 |
| Recruiting | A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Hepatocellular Carcinoma | Phase 2 | 2024-07-15 |
| Completed | A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects Healthy Volunteers | Phase 1 | 2024-06-17 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Ulcerative Colitis | Phase 2 | 2024-05-01 |
| Completed | Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertini Colorectal Cancer, Non-Small Cell Lung Cancer | Phase 1 | 2024-01-08 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combinati Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors | Phase 1 | 2023-11-27 |
| Recruiting | A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFO Adenocarcinoma, Pancreatic Ductal | Phase 2 | 2023-10-18 |
| Active Not Recruiting | A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibit Non-small Cell Lung Cancer, Gastric Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1 | 2023-10-02 |
| Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab Relapsed or Refractory Multiple Myeloma | Phase 1 | 2023-08-10 |
| Terminated | A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis a Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement | Phase 2 | 2023-05-26 |
| Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Me Advanced Prostate Cancer, Metastatic Prostate Cancer | Phase 1 | 2023-05-02 |
| Completed | A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Particip Acute Graft-versus-host Disease | Phase 1 | 2023-04-06 |
| Recruiting | A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participant Geographic Atrophy | Phase 2 | 2023-03-23 |
| Completed | A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patient Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma, Unexplained Chronic Cough | Phase 2 | 2023-03-22 |
| Active Not Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Multiple Myeloma | Phase 1 | 2023-03-21 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Systemic Sclerosis | Phase 1 | 2023-01-16 |
| Active Not Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 Diabetic Macular Edema | Phase 1 | 2022-12-08 |
| Completed | A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives Specialist Referral: Neurology, Specialist Referral: Ophthalmology, Specialist Referral: Oncology | — | 2022-12-02 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combinat Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC | Phase 1 | 2022-10-20 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | 2022-08-17 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choic Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2022-08-03 |
| Withdrawn | A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria | Phase 2 | 2022-07-31 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone o Diabetic Macular Edema | Phase 1 / Phase 2 | 2022-06-22 |
| Active Not Recruiting | An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration Age-Related Macular Degeneration | — | 2022-05-27 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participan Multiple Myeloma | Phase 1 | 2022-04-28 |
| Active Not Recruiting | Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) Spinal Muscular Atrophy | Phase 4 | 2022-03-29 |
| Active Not Recruiting | A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabeti Diabetic Macular Edema | Phase 4 | 2022-02-28 |
| Active Not Recruiting | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants Wit Non-Hodgkin Lymphoma | Phase 2 | 2022-02-01 |
| Recruiting | A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration Neovascular Age-related Macular Degeneration | Phase 4 | 2021-12-14 |
| Terminated | A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin Chronic Obstructive Pulmonary Disease | Phase 2 | 2021-11-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Chronic Obstructive Pulmonary Disease | Phase 2 | 2021-10-05 |
| Active Not Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or R Multiple Myeloma | Phase 1 | 2021-07-26 |
| Active Not Recruiting | A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either C Melanoma | Phase 1 | 2021-05-13 |
| Completed | A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations Advanced Unresectable or Metastatic Solid Malignancy | Phase 2 | 2021-01-13 |
| Completed | Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-9545 Following a Single Oral Dose Healthy Volunteers | Phase 1 | 2021-01-07 |
| Terminated | A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Parti Moderate-to-severe Allergic Asthma | Phase 4 | 2020-11-30 |
| Completed | Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care i Acute Graft-versus-host Disease | Phase 1 | 2020-11-19 |
| Terminated | A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geograp Macular Degeneration, Age-Related, Geographic Atrophy | Phase 2 | 2020-11-16 |
| Recruiting | A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Non-small Cell Lung Cancer | Phase 2 | 2020-11-06 |
| Completed | Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Alzheimer Disease (AD) | Phase 1 | 2020-10-26 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participa Non-alcoholic Steatohepatitis | Phase 2 | 2020-09-30 |
| Completed | A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 | 2020-08-31 |
| Completed | A Study of the Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants Alzheimer Disease | Phase 1 | 2020-08-11 |
| Completed | Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple S Multiple Sclerosis, Relapsing | Phase 4 | 2020-07-30 |
| Active Not Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Particip Non-Small Cell Lung Cancer, Colorectal Cancer, Advanced Solid Tumors | Phase 1 | 2020-07-29 |
| Completed | A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 1 | 2020-07-08 |
| Completed | A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe CO COVID-19 Pneumonia | Phase 2 | 2020-06-02 |
| Completed | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumoni COVID-19 Pneumonia | Phase 3 | 2020-05-14 |
| Active Not Recruiting | An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizum Solid Tumors | Phase 1 | 2020-03-09 |
| Completed | Evaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing Healthy Volunteers | Phase 1 | 2020-03-06 |
| Completed | Prospective Clinicogenomic Program Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC) | Phase 4 | 2019-12-13 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Asthma | Phase 2 | 2019-10-31 |
| Completed | A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positi Breast Cancer | Phase 1 | 2019-07-26 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Ac Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma | Phase 1 | 2019-07-22 |
| Completed | A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. Solid Tumor | Phase 1 | 2019-06-06 |
| Terminated | A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geogra Macular Degeneration, Age-Related, Geographic Atrophy | Phase 2 | 2019-06-03 |
| Completed | A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic D Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen Planus | Phase 2 | 2019-05-29 |
| Completed | Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodulari Prurigo Nodularis, Pruritis | Phase 2 | 2019-03-11 |
| Completed | Tenecteplase in Stroke Patients Between 4.5 and 24 Hours THROMBOLYSIS | Phase 3 | 2019-03-02 |
| Completed | A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatit Atopic Dermatitis | Phase 2 | 2019-02-06 |
| Completed | A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Healthy Volunteers | Phase 1 | 2019-02-01 |
| Completed | A Study of Semorinemab in Patients With Moderate Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2019-01-25 |
| Terminated | An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderat Ulcerative Colitis, Crohn's Disease | Phase 2 | 2019-01-14 |
| Completed | A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted C Healthy Volunteers | Phase 1 | 2019-01-10 |
| Completed | A Study to Investigate the Relative Bioavailability of Entrectinib Capsule Formulations F1 and F06 Under Fed C Healthy Volunteers | Phase 1 | 2019-01-09 |
| Completed | A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizuma Advanced Melanoma | Phase 2 | 2018-12-21 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Ved Ulcerative Colitis | Phase 2 | 2018-10-26 |
| Terminated | A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Urticaria | Phase 2 | 2018-09-27 |
| Completed | A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants Wi Multiple Sclerosis | Phase 3 | 2018-09-14 |
| Completed | A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced o Non-small Cell Lung Cancer | Phase 2 | 2018-08-10 |
| Terminated | Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Hemophilia A | Phase 4 | 2018-06-28 |
| Active Not Recruiting | A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers Solid Tumors | Phase 1 | 2018-06-06 |
| Completed | Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Breast Cancer | Phase 1 | 2018-04-17 |
| Terminated | An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 2 | 2018-01-09 |
| Completed | A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participan Melanoma, Non-Small Cell Lung Cancer, Bladder Cancer | Phase 1 | 2017-12-21 |
| Terminated | A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascen Healthy Volunteers | Phase 1 | 2017-12-08 |
| Active Not Recruiting | A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHR Breast Cancer | Phase 1 | 2017-11-24 |
| Completed | A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Leukemia, Myeloid, Acute | Phase 1 | 2017-11-15 |
| Completed | A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Pa Hepatic Insufficiency | Phase 1 | 2017-11-09 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Dise Alzheimer's Disease | Phase 2 | 2017-10-04 |
| Completed | Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Relat Geographic Atrophy | Phase 1 | 2017-09-21 |
| Completed | Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) Multiple Myeloma | Phase 1 | 2017-09-19 |
| Completed | Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 i Amyotrophic Lateral Sclerosis | Phase 1 | 2017-08-07 |
| Completed | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylo Bacteremia | Phase 1 | 2017-07-13 |
| Completed | A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). Urticaria | Phase 2 | 2017-05-26 |
| Terminated | A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Urothelial Carcinoma | Phase 2 | 2017-04-27 |
| Completed | A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Non-Small Cell Lung Cancer | Phase 2 | 2017-04-20 |
| Completed | A Study to Investigate the Effect of Formulation, Food, and Rabeprazole on the Pharmacokinetics (PK) of GDC-08 Healthy Volunteers | Phase 1 | 2017-04-18 |
| Completed | A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin Healthy Participants | Phase 1 | 2017-04-18 |
| Completed | A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 D Diabetes Mellitus, Type 2, Non-Alcoholic Fatty Liver Disease | Phase 1 | 2017-03-05 |
| Completed | A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus E Systemic Lupus Erythematosus | Phase 2 | 2017-01-19 |
| Active Not Recruiting | To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Sol Breast Cancer, Solid Tumor | Phase 1 | 2016-12-13 |
| Completed | A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe Wit Healthy Volunteers | Phase 1 | 2016-12-07 |
| Completed | A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheu Rheumatoid Arthritis | Phase 2 | 2016-11-30 |
| Completed | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Neuropathic Diabetic Foot Ulcers | Phase 1 | 2016-11-14 |
| Completed | A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults Influenza A | Phase 2 | 2016-10-12 |
| Completed | A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2016-09-23 |
| Completed | Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Art Rheumatoid Arthritis | Phase 2 | 2016-09-09 |
| Completed | A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease Alzheimer's Disease | Phase 1 | 2016-06-29 |
| Withdrawn | A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Healthy Volunteer | Phase 1 | 2016-06-01 |
| Completed | A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants Amyotrophic Lateral Sclerosis | Phase 1 | 2016-05-31 |
| Completed | A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Stea Metastatic Melanoma, BRAF V600 Mutation Positive | Phase 1 | 2016-05-26 |
| Completed | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Advanced/Metastatic Tumors | Phase 1 | 2016-05-23 |
| Completed | A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants Healthy Volunteers | Phase 1 | 2016-05-01 |
| Completed | Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Mult Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive | Phase 3 | 2016-04-29 |
| Completed | A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerati Ulcerative Colitis, Crohn's Disease | Phase 1 | 2016-04-11 |
| Completed | A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Mild Atopic Asthma | Phase 1 | 2016-04-07 |
| Completed | A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Ve Macular Edema | Phase 3 | 2016-03-21 |
| Completed | A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Subop Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2016-02-11 |
| Completed | Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810 Healthy Volunteer | Phase 1 | 2016-01-06 |
| Completed | Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Al Alzheimer's Disease | Phase 1 | 2015-12-23 |
| Completed | A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 Metastatic Breast Cancer | Phase 2 | 2015-12-16 |
| Terminated | A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resis Breast Cancer | Phase 2 | 2015-12-04 |
| Completed | Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Poten Breast Cancer | Phase 1 | 2015-12-01 |
| Completed | A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Aut Healthy Volunteer | Phase 1 | 2015-12-01 |
| Completed | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers Healthy Volunteer | Phase 1 | 2015-11-29 |
| Approved For Marketing | An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcin Urothelial Carcinoma | — | 2015-11-01 |
| Completed | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Insulin Resistance | Phase 1 | 2015-10-29 |
| Completed | Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subj Cancer | Phase 1 | 2015-10-01 |
| Completed | Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab Macular Degeneration | Phase 2 | 2015-09-28 |
| Completed | A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin | Phase 1 / Phase 2 | 2015-09-15 |
| Completed | A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers Healthy Volunteer | Phase 1 | 2015-09-15 |
| Completed | Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Eff Healthy Volunteer | Phase 1 | 2015-09-03 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers Healthy Volunteer | Phase 1 | 2015-08-18 |
| Completed | A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumor | Phase 1 | 2015-07-28 |
| Completed | A Bioequivalence Study of Subcutaneous (SC) Lebrikizumab Administered by Needle and Syringe or by Prefilled Sy Healthy Volunteer | Phase 1 | 2015-07-01 |
| Completed | A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma | Phase 1 | 2015-06-16 |
| Completed | A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants Healthy Volunteer | Phase 1 | 2015-06-01 |
| Completed | A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urti Urticaria | Phase 4 | 2015-05-18 |
| Completed | A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Ant Neoplasms | Phase 1 | 2015-04-24 |
| Completed | A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formul Healthy Volunteer | Phase 1 | 2015-04-01 |
| Completed | A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leuk Chronic Lymphocytic Leukemia | Phase 2 | 2015-03-31 |
| Completed | A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) In Growth Hormone Deficiency | Phase 4 | 2015-03-31 |
| Completed | A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participan Geographic Atrophy | Phase 2 | 2015-03-30 |
| Completed | A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Bre Breast Cancer | Phase 1 | 2015-03-17 |
| Completed | A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Volunteer | Phase 1 | 2015-03-01 |
| Completed | A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease Alzheimer Disease | Phase 1 | 2015-02-26 |
| Completed | A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants Wit Breast Cancer | Phase 2 | 2015-02-17 |
| Completed | A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza Influenza | Phase 2 | 2015-01-14 |
| Terminated | A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hor Breast Cancer | Phase 1 / Phase 2 | 2014-12-29 |
| Completed | A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast C Breast Cancer | Phase 2 | 2014-11-12 |
| Completed | A Study of High Dose MHAA4549A in Healthy Volunteers Healthy Volunteer | Phase 1 | 2014-11-03 |
| Completed | A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With B Breast Neoplasms | Phase 2 | 2014-08-19 |
| Completed | A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Neoplasms | Phase 1 | 2014-08-12 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage Healthy Volunteer | Phase 1 | 2014-08-01 |
| Completed | A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovaria Pancreatic Neoplasms, Ovarian Neoplasms | Phase 1 | 2014-06-22 |
| Terminated | A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke Stroke | Phase 3 | 2014-05-31 |
| Completed | My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentri Neoplasms, Solid Tumors, Biliary Cancer | Phase 2 | 2014-04-14 |
| Completed | A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volun Healthy Volunteer | Phase 1 | 2014-04-01 |
| Completed | A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC Healthy Volunteer | Phase 1 | 2014-04-01 |
| Completed | Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors Solid Tumor | Phase 1 | 2014-04-01 |
| Completed | A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors Neoplasms | Phase 1 | 2014-04-01 |
| Terminated | A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Re Ovarian Cancer | Phase 2 | 2014-02-06 |
| Completed | A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers Healthy Volunteer | Phase 1 | 2014-02-01 |
| Completed | A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participa Chronic Lymphocytic Leukemia | Phase 1 | 2014-01-13 |
| Completed | A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Ef Alzheimer's Disease | Phase 2 | 2013-12-20 |
| Completed | A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia. Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma | Phase 1 | 2013-12-16 |
| Completed | A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian C Non-Squamous Non-Small Cell Lung Cancer | Phase 1 | 2013-12-16 |
| Completed | A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria Urticaria | Phase 2 | 2013-12-01 |
| Completed | A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, a Lymphoma, Non Hodgkin | Phase 1 / Phase 2 | 2013-11-29 |
| Completed | A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model Healthy Volunteer | Phase 2 | 2013-11-25 |
| Completed | A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in H Healthy Volunteer | Phase 1 | 2013-11-01 |
| Completed | A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers Healthy Volunteer | Phase 1 | 2013-11-01 |
| Completed | A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS Neoplasms | Phase 1 | 2013-11-01 |
| Completed | Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disea Systemic Sclerosis | Phase 2 | 2013-10-01 |
| Completed | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Head and Neck Cancer | Phase 1 | 2013-09-19 |
| Completed | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With A Gastric Cancer | Phase 2 | 2013-08-14 |
| Completed | An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Unt Chronic Lymphocytic Leukemia | Phase 2 | 2013-08-01 |
| Completed | A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination Wi Breast Cancer, Non-small Lung Cancer | Phase 1 | 2013-07-16 |
| Completed | A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants Healthy Participants | Phase 1 | 2013-07-01 |
| Completed | A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers Healthy Volunteer | Phase 1 | 2013-07-01 |
| Completed | A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors Solid Tumor | Phase 1 | 2013-06-21 |
| Completed | A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Me Non-Small Cell Lung Cancer | Phase 2 | 2013-05-30 |
| Completed | A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers Healthy Volunteer | Phase 1 | 2013-04-01 |
| Completed | A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or M Breast Cancer | Phase 2 | 2013-02-06 |
| Completed | A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetic Healthy Volunteer | Phase 1 | 2013-02-01 |
| Completed | A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Rec Cytomegalovirus Infections | Phase 2 | 2012-12-14 |
| Completed | A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer' Alzheimer's Disease | Phase 2 | 2012-12-07 |
| Completed | The Management of Schizophrenia in Clinical Practice (MOSAIC) Schizophrenia | — | 2012-12-01 |
| Completed | A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer Sy Cystic Fibrosis | Phase 4 | 2012-12-01 |
| Completed | A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies Multiple Myeloma, Neoplasms | — | 2012-12-01 |
| Completed | A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia Lymphocytic Leukemia, Chronic | Phase 1 | 2012-11-29 |
| Recruiting | The Mycophenolate Pregnancy Registry Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases | — | 2012-11-20 |
| Completed | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Particip Colorectal Cancer | Phase 2 | 2012-10-01 |
| Completed | A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined Follicular Lymphoma, Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2012-09-27 |
| Completed | A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers Healthy Volunteer | Phase 1 | 2012-09-01 |
| Completed | A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participan Malignant Melanoma | Phase 1 | 2012-08-13 |
| Completed | A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Sever Rheumatoid Arthritis | Phase 3 | 2012-08-01 |
| Completed | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants Cancer | Phase 1 | 2012-07-11 |
| Completed | A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Hea Head and Neck Cancer | Phase 2 | 2012-07-01 |
| Completed | An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Granulomatosis With Polyangiitis, Microscopic Polyangiitis | — | 2012-06-20 |
| Terminated | An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carc Basal Cell Carcinoma | — | 2012-06-20 |
| Completed | An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) Breast Cancer | — | 2012-06-05 |
| Terminated | An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Geographic Atrophy | Phase 2 | 2012-05-29 |
| Completed | A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk Coronary Heart Disease | Phase 2 | 2012-05-01 |
| Completed | A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma Glioblastoma, Glioma | Phase 1 | 2012-04-01 |
| Completed | A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Asthma | Phase 2 | 2012-04-01 |
| Completed | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 Whe Neoplasms | Phase 1 | 2012-04-01 |
| Completed | A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | 2012-04-01 |
| Completed | A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With S Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | 2012-04-01 |
| Completed | A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma, Solid Tumor | Phase 1 | 2012-03-23 |
| Completed | A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Var Cancer | Phase 1 | 2012-03-01 |
| Completed | A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Con Asthma | Phase 2 | 2012-03-01 |
| Completed | A Study of MCAF5352A in Healthy Volunteers Healthy Volunteer | Phase 1 | 2012-03-01 |
| Completed | An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizin Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer | — | 2012-03-01 |
| Completed | A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma Malignant Melanoma | Phase 1 | 2012-03-01 |
| Completed | A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second C Asthma | Phase 2 | 2012-03-01 |
| Completed | Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilis Non-Small Cell Lung Cancer | Phase 2 | 2012-01-20 |
| Completed | Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Ca Prostate Cancer | Phase 1 / Phase 2 | 2012-01-11 |
| Completed | A Study of RG7667 in Healthy Volunteers Healthy Volunteer | Phase 1 | 2012-01-01 |
| Completed | A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Po Non-Squamous Non-Small Cell Lung Cancer | Phase 3 | 2012-01-01 |
| Completed | Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Vol Healthy Volunteer | Phase 1 | 2011-12-01 |
| Completed | Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Ad Healthy Volunteer | Phase 1 | 2011-12-01 |
| Completed | A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma Endometrial Carcinoma | Phase 2 | 2011-12-01 |
| Completed | Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colit Ulcerative Colitis | Phase 2 | 2011-11-29 |
| Completed | A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer Ovarian Cancer | Phase 1 | 2011-11-01 |
| Completed | Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980 Healthy Volunteer | Phase 1 | 2011-11-01 |
| Completed | A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab a Metastatic Colorectal Cancer | Phase 2 | 2011-11-01 |
| Terminated | Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Mela Malignant Melanoma | Phase 2 | 2011-10-31 |
| Completed | A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Prev Lymphocytic Leukemia, Chronic | Phase 2 | 2011-10-31 |
| Withdrawn | A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Diffuse Large B-Cell Lymphoma | Phase 2 | 2011-10-01 |
| Completed | Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Ad Healthy Volunteer | Phase 1 | 2011-10-01 |
| Completed | Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in P Breast Cancer | Phase 2 | 2011-10-01 |
| Completed | Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed o Renal Cell Carcinoma | Phase 2 | 2011-10-01 |
| Completed | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastati Colorectal Cancer | Phase 2 | 2011-09-14 |
| Completed | A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With Solid Cancers | Phase 1 | 2011-09-01 |
| Completed | A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2011-09-01 |
| Completed | Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2011-09-01 |
| Completed | A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild Alzheimer's Disease | Phase 2 | 2011-08-31 |
| Completed | A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Lymphoma, B-Cell | Phase 2 | 2011-08-31 |
| Completed | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants Wit Colorectal Cancer | Phase 2 | 2011-08-01 |
| Completed | A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers Healthy Volunteer | Phase 1 | 2011-08-01 |
| Completed | Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2011-08-01 |
| Completed | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Neoplasms | Phase 1 | 2011-07-11 |
| Completed | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Ge Solid Tumor | Phase 1 | 2011-07-11 |
| Completed | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Solid Cancers | Phase 1 | 2011-07-01 |
| Completed | A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tol Tumors, Hematologic Malignancies | Phase 1 | 2011-06-21 |
| Completed | Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer ( Non-Small Cell Lung Cancer, Ovarian Cancer | Phase 1 | 2011-06-14 |
| Completed | Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumor Non-Hodgkin's Lymphoma, Solid Tumor | Phase 1 | 2011-06-01 |
| Completed | Patient Reported Symptoms in Ovarian Cancer (PRECISION) Ovarian Cancer | — | 2011-06-01 |
| Completed | Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 3 | 2011-06-01 |
| Completed | Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizu Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | 2011-06-01 |
| Completed | A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Un Lymphocytic Leukemia, Chronic | Phase 1 | 2011-05-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2011-04-30 |
| Completed | Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovaria Ovarian Cancer, Pancreatic Cancer | Phase 1 | 2011-04-01 |
| Completed | A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodg Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | 2011-03-22 |
| Terminated | A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanc Solid Cancers, Non-Hodgkin's Lymphoma | Phase 1 | 2011-03-16 |
| Completed | A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Chronic Idiopathic Urticaria | Phase 3 | 2011-03-01 |
| Completed | Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in P Breast Cancer | Phase 2 | 2011-03-01 |
| Completed | A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castra Prostate Cancer | Phase 1 | 2011-03-01 |
| Completed | A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Mon Geographic Atrophy | Phase 2 | 2011-02-01 |
| Completed | A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomat Chronic Idiopathic Urticaria | Phase 3 | 2011-02-01 |
| Completed | A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/ Chronic Idiopathic Urticaria | Phase 3 | 2011-02-01 |
| Completed | A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Mac Macular Edema | Phase 4 | 2011-02-01 |
| Completed | A Study to Evaluate the Effect of a Proton-Pump Inhibitor (Rabeprazole) on the Relative Bioavailability of Cob Healthy Volunteer | Phase 1 | 2011-01-01 |
| Completed | A Study of Relative Bioavailability and Food Effect Study of Cobimetinib in Healthy Participants Healthy Volunteers | Phase 1 | 2010-12-01 |
| Completed | Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Breast Cancer | Phase 1 | 2010-12-01 |
| Completed | A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SO Asthma | Phase 2 | 2010-12-01 |
| Completed | A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastat Epithelial Tumors, Malignant | Phase 1 | 2010-11-09 |
| Completed | A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positi Multiple Myeloma | Phase 1 | 2010-11-01 |
| Completed | A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination Wi Solid Cancers | Phase 1 | 2010-11-01 |
| Completed | An Absolute Bioavailability Study in Healthy Participants Comparing Oral to Intravenous Administration of GDC- Healthy Volunteers | Phase 1 | 2010-11-01 |
| Terminated | A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device Growth Hormone Deficiency | — | 2010-11-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumati Rheumatoid Arthritis | Phase 2 | 2010-11-01 |
| Completed | A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoco Healthy Volunteer | Phase 1 | 2010-11-01 |
| Completed | A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the E Healthy Volunteer | Phase 1 | 2010-10-14 |
| Completed | A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Ref Solid Cancers | Phase 1 | 2010-10-01 |
| Completed | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma Basal Cell Carcinoma | Phase 2 | 2010-10-01 |
| Completed | A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refra Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | 2010-10-01 |
| Completed | A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Rheumatoid Arthritis | Phase 4 | 2010-09-01 |
| Completed | A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects Healthy Volunteer | Phase 1 | 2010-08-25 |
| Completed | A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previou Chronic Lymphocytic Leukemia | Phase 2 | 2010-08-01 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic R Allergic Rhinitis | Phase 1 | 2010-07-11 |
| Approved For Marketing | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Basal Cell Carcinoma | — | 2010-07-01 |
| Completed | A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in C Solid Cancers | Phase 1 | 2010-06-01 |
| Completed | A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy Allergic Asthma | Phase 4 | 2010-05-01 |
| No Longer Available | A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer Metastatic Breast Cancer | — | 2010-05-01 |
| Completed | A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) Non-Hodgkin's Lymphoma | Phase 3 | 2010-04-30 |
| Completed | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advance Solid Cancers | Phase 1 | 2010-04-01 |
| Completed | A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors Solid Cancers | Phase 1 | 2010-03-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of Atherosclerosis | Phase 2 | 2010-03-01 |
| Completed | A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel Solid Cancers | Phase 1 | 2010-02-01 |
| Completed | A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticos Asthma | Phase 2 | 2009-11-01 |
| Terminated | Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Local Solid Tumors | Phase 1 | 2009-11-01 |
| Completed | A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effec Healthy Volunteers | Phase 1 | 2009-10-26 |
| Completed | A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy V Healthy Volunteer | Phase 1 | 2009-10-01 |
| Completed | A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel Non-Squamous Non-Small Cell Lung Cancer | Phase 1 | 2009-10-01 |
| Completed | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I Ovarian Cancer, Basal Cell Carcinoma, Metastatic Colorectal Cancer | Phase 2 | 2009-09-01 |
| Completed | A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Sol Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers | Phase 1 | 2009-09-01 |
| Completed | A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD45 Geographic Atrophy | Phase 1 | 2009-09-01 |
| Completed | A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential Healthy | Phase 1 | 2009-09-01 |
| Completed | A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic A Asthma | Phase 2 | 2009-09-01 |
| Completed | A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors Th Solid Cancers | Phase 1 | 2009-09-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Sys Systemic Lupus Erythematosus | Phase 2 | 2009-09-01 |
| Completed | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced Metastatic Breast Cancer | Phase 1 / Phase 2 | 2009-08-01 |
| Completed | A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trast Breast Cancer | Phase 1 | 2009-08-01 |
| Completed | A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advan Solid Cancers | Phase 1 | 2009-08-01 |
| Completed | Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients Wi Metastatic Breast Cancer | Phase 1 | 2009-07-01 |
| Completed | A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Prese Solid Cancers | Phase 1 | 2009-07-01 |
| Completed | Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Metastatic Breast Cancer | Phase 2 | 2009-07-01 |
| Completed | A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Ag Age-related Macular Degeneration | Phase 3 | 2009-07-01 |
| Completed | A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled C Asthma | Phase 2 | 2009-07-01 |
| Completed | A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors Solid Cancers | Phase 1 | 2009-05-22 |
| Completed | A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previ Metastatic Colorectal Cancer | Phase 1 | 2009-05-01 |
| Completed | A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2009-05-01 |
| Completed | A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Non-Hodgkin's Lymphoma, Solid Cancers | Phase 1 | 2009-05-01 |
| Completed | A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Pre Metastatic Colorectal Cancer | Phase 1 | 2009-05-01 |
| Completed | A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarce Non-Small Cell Lung Cancer | Phase 2 | 2009-04-01 |
| Terminated | A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Rheumatoid Arthritis | Phase 2 | 2009-03-05 |
| Completed | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2009-03-01 |
| Completed | A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Non-Hodgkin's Lymphoma, Solid Cancers | Phase 1 | 2009-03-01 |
| Completed | A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Chronic Idiopathic Urticaria | Phase 2 | 2009-03-01 |
| Completed | Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent Allergic Asthma | — | 2009-03-01 |
| Completed | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients Wi Basal Cell Carcinoma | Phase 2 | 2009-02-01 |
| Completed | A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab i Breast Cancer, Pregnancy | — | 2009-01-14 |
| Completed | A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian C Ovarian Cancer | Phase 2 | 2008-12-01 |
| Completed | A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild All Allergic Asthma | Phase 2 | 2008-12-01 |
| Active Not Recruiting | A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansin Neoplasm Metastasis | Phase 2 | 2008-10-16 |
| Suspended | A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer | Phase 1 | 2008-09-01 |
| Completed | A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patien Ulcerative Colitis | Phase 1 | 2008-09-01 |
| Completed | A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors Solid Cancers | Phase 1 | 2008-09-01 |
| Completed | Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 3 | 2008-08-01 |
| Completed | A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Pat Alzheimer's Disease | Phase 1 | 2008-08-01 |
| Completed | A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Can Metastatic Breast Cancer | Phase 2 | 2008-08-01 |
| Completed | The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipient Healthy, Asthma | Phase 4 | 2008-08-01 |
| Completed | A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting | Phase 2 | 2008-07-17 |
| Completed | An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Ve Macular Edema, Retinal Vein Occlusion | N/A | 2008-07-01 |
| Completed | A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Fol Non-Hodgkin's Lymphoma | Phase 3 | 2008-07-01 |
| Terminated | A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthrit Rheumatoid Arthritis | Phase 1 | 2008-07-01 |
| Terminated | A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis Cystic Fibrosis | Phase 4 | 2008-06-01 |
| Completed | An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Ca Breast Cancer | — | 2008-06-01 |
| Completed | A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Multiple Myeloma | Phase 1 | 2008-05-01 |
| Completed | A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As F Metastatic Colorectal Cancer | Phase 2 | 2008-05-01 |
| Terminated | A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadeq Rheumatoid Arthritis | Phase 3 | 2008-04-24 |
| Completed | A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Non-Hodgkin's Lymphoma | Phase 2 | 2008-03-01 |
| Completed | A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Non-Hodgkin's Lymphoma, Solid Cancers | Phase 1 | 2008-03-01 |
| Terminated | A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) Lupus Nephritis, Systemic Lupus Erythematosus | Phase 3 | 2008-02-15 |
| Completed | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously U Metastatic Breast Cancer | Phase 3 | 2008-02-12 |
| Completed | A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Pso Psoriasis | Phase 4 | 2008-02-01 |
| Terminated | A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) Systemic Lupus Erythematosus | Phase 3 | 2007-12-19 |
| Completed | A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B Non-Hodgkin's Lymphoma | Phase 1 | 2007-12-01 |
| Completed | A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therap Solid Cancers | Phase 1 | 2007-10-01 |
| Completed | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Beva Colorectal Cancer | Phase 1 | 2007-10-01 |
| Completed | A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic As Allergic Asthma | Phase 2 | 2007-10-01 |
| Completed | A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patient Asthma | Phase 4 | 2007-09-01 |
| Completed | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With A Adenocarcinoma | Phase 3 | 2007-09-01 |
| Terminated | A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphoc Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2007-08-27 |
| Terminated | A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients Wit Renal Cell Carcinoma | Phase 2 | 2007-08-01 |
| Completed | A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor Solid Cancers | Phase 1 | 2007-08-01 |
| Completed | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Centra Macular Edema, Retinal Vein Occlusion | Phase 3 | 2007-07-01 |
| Completed | A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Macular Edema, Retinal Vein Occlusion | Phase 3 | 2007-07-01 |
| Completed | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epide Metastatic Breast Cancer | Phase 2 | 2007-07-01 |
| Terminated | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Rheumatoid Arthritis | Phase 3 | 2007-06-11 |
| Completed | A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g Non-Small Cell Lung Cancer | Phase 2 | 2007-06-01 |
| Completed | A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involv Diabetes Mellitus, Macular Edema | Phase 3 | 2007-06-01 |
| Completed | A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2007-06-01 |
| Terminated | A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Ad Solid Cancers | Phase 1 | 2007-06-01 |
| Withdrawn | A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab Carcinoma | — | 2007-06-01 |
| Completed | A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involv Diabetes Mellitus, Macular Edema | Phase 3 | 2007-06-01 |
| Terminated | A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g) Chondrosarcoma | Phase 2 | 2007-05-31 |
| Terminated | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Respo Rheumatoid Arthritis | Phase 3 | 2007-05-15 |
| Terminated | A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Ho Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2007-05-01 |
| Completed | Study of Cobimetinib in Participants With Solid Tumors Solid Tumor | Phase 1 | 2007-05-01 |
| Completed | A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Ovarian Cancer | Phase 3 | 2007-04-01 |
| Completed | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2007-04-01 |
| Terminated | A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Meta Metastatic Breast Cancer | Phase 2 | 2007-03-01 |
| Terminated | A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced No Non-Small Cell Lung Cancer | Phase 2 | 2007-03-01 |
| Terminated | A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TO Cystic Fibrosis | Phase 4 | 2007-03-01 |
| Completed | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) Small Cell Lung Cancer | Phase 2 | 2007-03-01 |
| Completed | A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2007-02-01 |
| Completed | A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients W Melanoma | Phase 2 | 2007-02-01 |
| Completed | A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previou Rheumatoid Arthritis | — | 2007-01-01 |
| Completed | A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheu Rheumatoid Arthritis | Phase 3 | 2007-01-01 |
| Terminated | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexat Rheumatoid Arthritis | Phase 3 | 2006-12-27 |
| Completed | A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters Dysfunctional Central Venous Access Catheters | Phase 3 | 2006-12-01 |
| Completed | A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2006-12-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma Allergic Asthma | Phase 2 | 2006-12-01 |
| Completed | A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters Dysfunctional Hemodialysis Catheters | Phase 3 | 2006-11-01 |
| Completed | A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters Dysfunctional Central Venous Access Catheters | Phase 3 | 2006-11-01 |
| Completed | A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g Peanut Hypersensitivity | Phase 2 | 2006-11-01 |
| Completed | A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Colorectal Cancer, Non-Small Cell Lung Cancer | — | 2006-11-01 |
| Completed | An Observational Study of the Use and Safety of Xolair® During Pregnancy Asthma | — | 2006-10-20 |
| Completed | A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters Dysfunctional Hemodialysis Catheters | Phase 3 | 2006-10-01 |
| Completed | Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 3 | 2006-07-14 |
| Completed | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Wi Colorectal Cancer | Phase 1 | 2006-07-01 |
| Completed | A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multifor Glioblastoma | Phase 2 | 2006-07-01 |
| Terminated | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 3 | 2006-06-22 |
| Terminated | A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, No Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2006-06-01 |
| Completed | A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadeq Psoriasis | Phase 4 | 2006-05-01 |
| Completed | A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Can Metastatic Breast Cancer | Phase 1 | 2006-04-01 |
| Completed | Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 3 | 2006-04-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving th Psoriasis | Phase 4 | 2006-03-30 |
| Completed | A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metast Non-Small Cell Lung Cancer, Brain Neoplasms | Phase 2 | 2006-03-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Trea Metastatic Breast Cancer | Phase 3 | 2006-02-01 |
| Completed | A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Asthma | Phase 4 | 2006-02-01 |
| Completed | A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2006-01-23 |
| Completed | A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheu Rheumatoid Arthritis | Phase 3 | 2006-01-01 |
| Completed | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lun Non-Small Cell Lung Cancer | Phase 3 | 2006-01-01 |
| Completed | A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate Rheumatoid Arthritis | Phase 3 | 2006-01-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/ Lupus Nephritis | Phase 3 | 2006-01-01 |
| Completed | A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Foot Ulcer, Diabetic | Phase 2 | 2006-01-01 |
| Unknown | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metast Metastatic Breast Cancer | Phase 3 | 2005-12-01 |
| Completed | A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA) Asthma | Phase 3 | 2005-12-01 |
| Completed | A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related M Choroidal Neovascularization, Age-related Macular Degeneration | Phase 3 | 2005-11-01 |
| Terminated | A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics Melanoma | Phase 1 | 2005-10-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotre Rheumatoid Arthritis | Phase 3 | 2005-10-01 |
| Completed | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamo Non-small Cell Lung Cancer | Phase 2 | 2005-09-01 |
| Completed | A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Recei Rheumatoid Arthritis | Phase 2 | 2005-08-01 |
| Completed | A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung C Non-Small Cell Lung Cancer | Phase 3 | 2005-06-08 |
| Completed | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 2 / Phase 3 | 2005-05-10 |
| Completed | A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Stud Solid Cancers | Phase 2 | 2005-05-01 |
| Terminated | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer Colorectal Cancer | Phase 4 | 2005-05-01 |
| Completed | An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascul Choroidal Neovascularization, Age-related Macular Degeneration | N/A | 2005-04-01 |
| Completed | A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Ps Psoriasis | — | 2005-03-01 |
| Completed | A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Fai Ovarian Cancer | Phase 2 | 2005-02-01 |
| Completed | A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 2 | 2005-01-01 |
| Completed | An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) Psoriasis, Pregnancy | — | 2005-01-01 |
| Completed | A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2004-12-01 |
| Completed | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Lung Cancer, Non-small-cell Lung Carcinoma | Phase 3 | 2004-08-01 |
| Completed | A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Re Macular Degeneration | Phase 3 | 2004-08-01 |
| Completed | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Sma Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local | Phase 2 | 2004-07-01 |
| Terminated | A Safety and Efficacy Study of Xolair in Peanut Allergy Allergy | Phase 2 | 2004-06-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis Multiple Sclerosis | Phase 2 / Phase 3 | 2004-06-01 |
| Completed | A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma Asthma | — | 2004-06-01 |
| Completed | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adeno Colorectal Cancer | — | 2004-03-01 |
| Completed | A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Renal Cell Carcinoma, Metastases | Phase 2 | 2004-03-01 |
| Completed | An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphom Lymphoma, Non Hodgkin | — | 2004-03-01 |
| Completed | A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 / Phase 2 | 2004-02-01 |
| Completed | A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Psoriasis | Phase 3 | 2003-10-01 |
| Completed | A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis Cystic Fibrosis | Phase 2 | 2003-09-01 |
| Completed | Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 2 | 2003-08-31 |
| Completed | A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of H Foot Ulcer | Phase 1 | 2003-08-01 |
| Completed | A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Glioblastoma | Phase 2 | 2003-07-01 |
| Completed | Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed Aft Non-small Cell Lung Cancer | Phase 2 | 2003-07-01 |
| Completed | Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2003-06-01 |
| Completed | A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis Plaque Psoriasis | Phase 1 | 2003-05-01 |
| Completed | A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degenerat Macular Degeneration | Phase 3 | 2003-05-01 |
| Completed | A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma Asthma | Phase 3 | 2003-05-01 |
| Completed | A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Ovarian Cancer | Phase 2 | 2003-05-01 |
| Completed | Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2003-04-01 |
| Completed | Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degener Age-Related Maculopathy | Phase 1 / Phase 2 | 2003-03-01 |
| Completed | A Study of Patients With HER2-Positive Metastatic Breast Cancer Breast Cancer | — | 2003-03-01 |
| Completed | A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degen Macular Degeneration | Phase 3 | 2003-03-01 |
| Completed | National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone Dwarfism, Pituitary | — | 2003-02-01 |
| Completed | A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600 Psoriasis | Phase 3 | 2002-10-01 |
| Completed | Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer Colorectal Cancer | Phase 1 | 2002-10-01 |
| Completed | A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study Breast Cancer, Colorectal Cancer, Metastases | Phase 3 | 2002-10-01 |
| Completed | Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) Macular Degeneration | Phase 3 | 2002-09-01 |
| Completed | A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Psoriasis | Phase 3 | 2002-09-01 |
| Completed | An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g Asthma | Phase 3 | 2002-06-01 |
| Completed | Cathflo Activase Pediatric Study Dysfunctional Central Venous Access Devices (CVADS) | Phase 4 | 2002-04-01 |
| Completed | A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (E Chronic Renal Insufficiency, End-Stage Renal Disease | — | 2002-03-01 |
| Completed | A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g Psoriasis | Phase 3 | 2002-01-01 |
| Completed | Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors Neoplasms | Phase 1 | 2001-11-01 |
| Completed | A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer Lung Cancer | Phase 3 | 2001-07-01 |
| Completed | A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemot Breast Cancer | Phase 2 | 2001-05-01 |
| Completed | A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies Psoriasis | Phase 4 | 2001-02-01 |
| Completed | A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Breast Cancer, Metastases | — | 2000-11-30 |
| Completed | A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Brea Breast Cancer | Phase 3 | 2000-11-01 |
| Completed | A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer Colorectal Cancer | Phase 3 | 2000-09-01 |
| Completed | An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and Acute Myocardial Infarction | — | 2000-09-01 |
| Completed | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2000-08-01 |
| Completed | A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO) Asthma | Phase 3 | 2000-07-01 |
| Completed | Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD) Dwarfism, Pituitary, Turner Syndrome | — | 2000-04-01 |
| Completed | Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 Breast Cancer | Phase 2 | 2000-01-01 |
| Completed | A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Di Cystic Fibrosis | — | 1999-10-01 |
| Completed | An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study Cancer | Phase 2 | 1998-02-01 |
| Completed | A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone Turner Syndrome | — | 1997-05-01 |
| Completed | National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nut Growth Disorders | — | 1985-10-01 |
| Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Re HIV Infections | Phase 1 | — |
| Approved For Marketing | An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Hemophilia A | — | — |
| Approved For Marketing | An Expanded Access Program for Risdiplam in Participants With Spinal Muscular Atrophy (SMA) Muscular Atrophy, Spinal | — | — |
| Completed | A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Th Immune Thrombocytopenic Purpura ( ITP ), HIV Infections | Phase 1 | — |
| Approved For Marketing | Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenido Idiopathic Pulmonary Fibrosis | — | — |
| Withdrawn | Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma Renal Cell Cancer | Phase 3 | — |
| Completed | A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volu HIV Infections | Phase 1 | — |
| Approved For Marketing | An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Do HER2-positive Breast Cancer | — | — |